A novel vaccine candidate based on chimeric virus-like particle displaying multiple conserved epitope peptides induced neutralizing antibodies against EBV infection

Theranostics - Tập 10 Số 13 - Trang 5704-5718 - 2020
Xiao Zhang1, Bingchun Zhao2,1, Mingmei Ding3, Shuo Song4, Yinfeng Kang1, Yang Yu1, Miao Xu1, Tong Xiang1, Ling Gao1, Qi‐Sheng Feng5,6, Qinjian Zhao7,1, Mu‐Sheng Zeng1, Claude Krummenacher8, Yi-Xin Zeng1
1. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Department of Experimental Research, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, Guangdong, PR China
2. Present address: Vaccine Research Center, National Institute of Allergy and Infection Diseases, National Institutes of Health, Bethesda, MD, United States
3. School of Medicine, Sun Yat-Sen University, Guangzhou, Guangdong, PR China
4State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, Xiamen University, Xiamen, China
5School of Public Health, Xiamen University, Xiamen, Fujian 361005, PR China
6Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, PR China,
7. State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, Fujian, PR China
8. Department of Biological Sciences and Department of Molecular and Cellular Biosciences, Rowan University, Glassboro, NJ, United States

Tóm tắt

Từ khóa


Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Theranostics

Tập 10 Số 13

5704-5718

Thông tin tác giả